Phase I study of amrubicin plus cisplatin and concurrent accelerated hyperfractionated thoracic radiotherapy for limited‐disease small cell lung cancer: protocol of <scp>ACIST</scp> study-Reference-Cited by-同舟云学术

Phase I study of amrubicin plus cisplatin and concurrent accelerated hyperfractionated thoracic radiotherapy for limited‐disease small cell lung cancer: protocol of ACIST study

Published:2022-07-08 Issue:16 Volume:13 Page:2404-2409
ISSN:1759-7706
Container-title:Thoracic Cancer
language:en
Short-container-title:Thoracic Cancer

Author:

Akagi Kazumasa¹,Taniguchi Hirokazu¹^ORCID,Fukuda Minoru¹²^ORCID,Yamazaki Takuya³,Ono Sawana¹,Tomono Hiromi¹,Suyama Takayuki¹,Shimada Midori¹⁴,Gyotoku Hiroshi¹,Takemoto Shinnosuke¹,Yamaguchi Hiroyuki¹⁵,Dotsu Yosuke⁶,Senju Hiroaki⁶,Soda Hiroshi⁶^ORCID,Mizowaki Takashi⁷,Monzen Yoshio⁷,Ikeda Takaya⁸,Nagashima Seiji⁸,Tasaki Yutaro³⁹,Nakamura Daisuke⁹,Komiya Kazutoshi¹⁰,Nakatomi Katsumi¹⁰,Sasaki Eisuke¹⁰,Hirakawa Koichi¹¹,Mukae Hiroshi¹

Affiliation:

1. Department of Respiratory Medicine Nagasaki University Graduate School of Biomedical Sciences Nagasaki Japan

2. Department of Respiratory Medicine Nagasaki Prefecture Shimabara Hospital Shimabara Japan

3. Department of Radiology Nagasaki University Hospital Nagasaki Japan

4. Clinical Research Center Nagasaki University Hospital Nagasaki Japan

5. Clinical Oncology Center Nagasaki University Hospital Nagasaki Japan

6. Department of Respiratory Medicine Sasebo City General Hospital Sasebo Japan

7. Department of Radiology Sasebo City General Hospital Sasebo Japan

8. Department of Respiratory Medicine National Hospital Organization Nagasaki Medical Center Omura Japan

9. Department of Radiology National Hospital Organization Nagasaki Medical Center Omura Japan

10. Department of Respiratory Medicine National Hospital Organization Ureshino Medical Center Ureshino Japan

11. Department of Radiology National Hospital Organization Ureshino Medical Center Ureshino Japan

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1759-7714.14555

Reference19 articles.

1. The Effect of Advances in Lung-Cancer Treatment on Population Mortality

2. Prognosis of limited-stage small cell lung cancer with comprehensive treatment including radical resection

3. Changing Epidemiology of Small-Cell Lung Cancer in the United States Over the Last 30 Years: Analysis of the Surveillance, Epidemiologic, and End Results Database

4. Twice-Daily Compared with Once-Daily Thoracic Radiotherapy in Limited Small-Cell Lung Cancer Treated Concurrently with Cisplatin and Etoposide

5. Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT): an open-label, phase 3, randomised, superiority trial